CompletedNot Applicable

"Finding Solid Ground" in Inpatient Treatment for Dissociative Disorder Patients Followed by Transition to Outpatient Treatment Settings: A 1-year Follow-up Pilot Study

Norway30 participantsStarted 2023-06-01

Plain-language summary

The purpose of the pilot is to examine the usefulness of the psychoeducational program, Finding Solid Ground, for patients with dissociative disorders in a naturalistc observational study, involving a 3-months inpatient treatment followed by patients continuation with the program in their local outpatient settings, by examining outcome of main trauma-related symptoms and adaptive coping. In addition, performing focus-group interviews with the patient groups at discharge and at follow-up, to gain information on their subjective experiences from participating in the program. The patients' therapists in the outpatient settings are invited to give written feedback on their experiences from working with FSG.

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The study include adults (minimum age of 18 years) with a complex dissociative disorder related to childhood trauma. All patients had received outpatient therapy with insufficient effect. Patients were diagnosed with at DSM-IV dissociative disorder, transformed to the ICD-10 dissociative disorders. Exclusion Criteria: * Ongoing psychosis, severe ongoing drug addiction, very disturbed group functioning, ongoing severe life crisis, mental disability, severe unsafe behavior (suicidality, self-harm).

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Progress in Treatment Questionnaire (PITQ-p)

Timeframe: at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

PTSD Checklist for DSM-5 (PCL-5)

Timeframe: assessmentsat respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

Difficulties in emotion regulation scale (DERS)

Timeframe: assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

Self-compassion Scale - Short Form (SCS-SF)

Timeframe: assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

Dissociative Experiences Scale (DES-II)

Timeframe: assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

Trial details

NCT IDNCT07432646

SponsorModum Bad

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-06-10

View on ClinicalTrials.gov More Dissociative Identity Disorder trials

Plain-language summary

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Progress in Treatment Questionnaire (PITQ-p)

Timeframe: at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

PTSD Checklist for DSM-5 (PCL-5)

Timeframe: assessmentsat respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

Difficulties in emotion regulation scale (DERS)

Timeframe: assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

Self-compassion Scale - Short Form (SCS-SF)

Timeframe: assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

Dissociative Experiences Scale (DES-II)

Timeframe: assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)